Cargando…
Type 1 interferon suppresses expression and glucocorticoid induction of glucocorticoid-induced leucine zipper (GILZ)
SLE is a systemic multi-organ autoimmune condition associated with reduced life expectancy and quality of life. Glucocorticoids (GC) are heavily relied on for SLE treatment but are associated with detrimental metabolic effects. Type 1 interferons (IFN) are central to SLE pathogenesis and may confer...
Autores principales: | Dankers, Wendy, Northcott, Melissa, Bennett, Taylah, D’Cruz, Akshay, Sherlock, Rochelle, Gearing, Linden J., Hertzog, Paul, Russ, Brendan, Miceli, Iolanda, Scheer, Sebastian, Fujishiro, Maki, Hayakawa, Kunihiro, Ikeda, Keigo, Morand, Eric F., Jones, Sarah A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727222/ https://www.ncbi.nlm.nih.gov/pubmed/36505447 http://dx.doi.org/10.3389/fimmu.2022.1034880 |
Ejemplares similares
-
Glucocorticoids and Glucocorticoid-Induced-Leucine-Zipper (GILZ) in Psoriasis
por: Sevilla, Lisa M., et al.
Publicado: (2019) -
Glucocorticoid-Induced Leucine Zipper (GILZ) in Cardiovascular Health and Disease
por: Cappetta, Donato, et al.
Publicado: (2021) -
Role of glucocorticoid-induced leucine zipper (GILZ) in inflammatory bone loss
por: Yang, Nianlan, et al.
Publicado: (2017) -
Glucocorticoid-induced leucine zipper (GILZ) in immuno suppression: master regulator or bystander?
por: Hoppstädter, Jessica, et al.
Publicado: (2015) -
Could GILZ Be the Answer to Glucocorticoid Toxicity in Lupus?
por: Flynn, Jacqueline K., et al.
Publicado: (2019)